Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
Summary
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Albireo
- ID
- NCT04336722
- Phase
- Phase 3 Biliary Atresia Research Study
- Study Type
- Interventional
- Participants
- Expecting 245 study participants
- Last Updated